Screener
Ocular Therapeutix OCUL Common Stock
Common Stock at other companies
Other financials
Where this comes from
Reported directly by Ocular Therapeutix in its filing.
Tagged under the XBRL concept us-gaap:CommonStockValue.
The source filing: Ocular Therapeutix’s 10-Q, filed May 5, 2026.
- Filed
- May 5, 2026, 7:28 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001104659-26-055256
| Line item | March 31, 2026 | December 31, 2025 |
|---|---|---|
| Commitments and contingencies (Note 14) | ||
| Stockholders’ equity: | ||
| Preferred stock, $0.0001 par value; 5,000,000 shares authorized and no shares issued or outstanding at March 31, 2026 and December 31, 2025, respectively | — | — |
| Common stock, $0.0001 par value; 400,000,000 and 400,000,000 shares authorized and 218,896,915 and 215,927,600 shares issued and outstanding at March 31, 2026 and December 31, 2025, respectively | 22 | 22 |
| Additional paid-in capital | 1,827,187 | 1,811,311 |
| Accumulated deficit | (1,245,635) | (1,157,023) |
| Total stockholders’ equity | 581,574 | 654,310 |
| Total liabilities and stockholders’ equity | $732,529 | $808,057 |
Item 1. Financial Statements (unaudited)
FAQ
- What is Ocular Therapeutix's common stock?
- Ocular Therapeutix (OCUL) reported common stock of $22K in Q1 2026.
- How has Ocular Therapeutix's common stock changed year-over-year?
- Ocular Therapeutix's common stock increased by 37.5% year-over-year, from $16K to $22K.
- What is the long-term trend for Ocular Therapeutix's common stock?
- Over 5 years (2020 to 2025), Ocular Therapeutix's common stock has grown at a 22.4% compound annual growth rate (CAGR), from $8K to $22K.
- What does common stock mean?
- The par value of all common shares issued and outstanding, typically a nominal amount ($0.01 or $0.001 per share).
Ask your AI about Ocular Therapeutix's common stock.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude